The net effect is improved glucose control
Lancet 403(10431):10271050 Lu Y, Hajifathalian K, Ezzati M, Woodward M, Rimm EB, Danaei G (2014) Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 18 million participants
Must not be used by persons with medical conditions
The researchers replicated the study using patients with Type 2 diabetes, and found similar results Kidney Disease: Semaglutide Could Prevent Chronic Issue Participants taking semaglutide who had Type 2 diabetes and chronic kidney disease had a 24% lower chance of experiencing a major kidney-related event like kidney failure, according to research by the New England Journal of Medicine
The vial should be used within 28 days of reconstitution
It is frequently associated with profound metabolic shifts that can increase your risk of chronic disease and impact your day-to-day life